FIELD: medicine.
SUBSTANCE: invention relates to 5-({6-amino-2-[4-(5-chlor-2-cyanophenyl)-5-methoxy-2-oxopyridine-1(2H)-yl]-3-methylhexanoyl}amino)pyrazolo[1,5-a]pyridine-3-carboxamide of the formula (I) or to one of its salts.
EFFECT: new compound is obtained, which can be used in medicine as an inhibitor of destructive activity of plasma kallikrein to produce drugs for the treatment and/or prevention of diseases, in particular cardiovascular diseases, preferably thrombotic or thromboembolic disorders and edema, as well as ophthalmic disorders.
3 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
OXOPICOLINAMIDE DERIVATIVE, A METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL USE THEREOF | 2017 |
|
RU2742771C2 |
6-HETEROCYCLYL-4-MORPHOLINE-4-ILPYRIDINE-2-ONES SUITABLE FOR THE TREATMENT OF CANCER AND DIABETES | 2017 |
|
RU2762968C2 |
ISOINDOLINONE INHIBITORS OF MDM2-P53 INTERACTION WITH ANTI-CANCER ACTIVITY | 2016 |
|
RU2794333C1 |
PYRIDINONE AND PYRIMIDINONE PHOSPHATES AND BORONATES USEFUL AS ANTIBACTERIAL AGENTS | 2019 |
|
RU2754177C1 |
SULFONAMIDE COMPOUNDS AND THEIR USE AS TNAP INHIBITORS | 2013 |
|
RU2627701C2 |
NEW 5,7-DISUBSTITUTED [1,3]THIAZOLO-[4,5-d]PYRIMIDIN-2(3H)-ONE DERIVATIVES AND THEIR APPLICATION IN THERAPY | 2007 |
|
RU2441012C2 |
SUBSTITUTED AMINO SIX-MEMBER SATURATED HETEROALICYCLES AS LONG-ACTING DPP-IV INHIBITORS | 2016 |
|
RU2720488C2 |
METHOD OF PRODUCING TWO 4-{[(2S)-2-{4-[5-CHLORO-2-(1H-1,2,3-TRIAZOL-1-YL)PHENYL]-5-METHOXY-2-OXOPYRIDIN-1(2H)-IL} BUTANOYL]AMINO}-2-FLUOROBENZAMIDE DERIVATIVES | 2019 |
|
RU2804663C2 |
ANILINE PYRIMIDINE DERIVATIVES AND USE THEREOF | 2016 |
|
RU2734849C2 |
NEW DERIVATIVES OF 5, 7-DISUBSTITUTED [1, 3] THIAZOLO[4, 5-D] PYRIMIDINE-2(3H)-ONE | 2006 |
|
RU2411245C9 |
Authors
Dates
2023-03-22—Published
2019-04-03—Filed